Whiting Samuel 4
4 · Tempest Therapeutics, Inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Whiting Samuel
Chief Medical Officer
Transactions
- Purchase
Common Stock
2024-07-02$2.13/sh+4,672$9,951→ 9,573 total
Footnotes (1)
- [F1]Includes 3,000 shares acquired under the Issuer's stock purchase plan.